A Study of Pulmonary Hypertension Peripheral Limitations

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Primary completion date changed from estimate of Sep 2026 to Jul 17, 2026
    • Eligibility criteria expanded, about 23 words
    • Secondary endpoints: details revised at 6 of 6 entries
  2. Re-verified, no change to tracked fieldsv9
  3. Primary and study completion dates: Mar 2028 to Sep 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v8
  4. Enrollment target: 40 to 45
    • Site contact updated
    v7
  5. Primary and study completion dates: Jul 2028 to Mar 2028v6
Show 4 earlier versionsHide 4 earlier versions
  1. Start date: Dec 7, 2023 to Jan 2, 2024v5
  2. Start date changed from estimate of Dec 2023 to Dec 7, 2023v4
  3. Start date: Oct 2023 to Dec 2023v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Aug 2023 to Oct 2023
    • Site details revised
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mayo Clinic
1,024 trials monitored
See 128 trials at risk
Hypertension
1,933 trials monitored
See 101 trials at risk
The investigators are doing this research study to compare whole body aerobic training with isolated leg training (with weights) and its impact on effectiveness in symptoms and quality of life in patients with Pulmonary Arterial Hypertension (PAH).
Trial Details
NCT Number NCT05968859
Lead Sponsor Mayo Clinic
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)		 Pulmonary Arterial Hypertension, Healthy
Related terms Pulmonary Arterial Hypertension
Enrollment 45 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov